EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Potent CRISPR-Cas12l Double-Strand Break Gene Editor

Tomas Urbaitis, Laima Trinkuniene, Ieva Lenkaite, Monika Petrauskyte, Renatas Krasauskas, Migle Stitilyte, Modestas Sabaliauskas, Giedrius Sasnauskas, Giedre Tamulaitiene, Joshua K Young, Virginijus Siksnys, Giedrius Gasiunas iD

The CRISPR Journal · 01.06.2026 · 9 (3) · 126-140

DOI: 10.1177/25731599261448428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 21.05.2026. Verfasst von Tomas Urbaitis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Caszyme, Vilnius, Lithuania. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, DNA Breaks, Double-Stranded, Gene Editing, CRISPR-Associated Proteins. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, a new family of CRISPR-Cas12 endonucleases from an unexplored phylum of bacteria, Armatimonadota , was discovered. Named Cas12l, they are compact (800–900 aa), recognize a 5′ C-rich protospacer adjacent motif, and present an N-terminal domain that stretches from the beginning to the end of the ribonucleoprotein-bound DNA target site, effectively locking it in place. Here, structure-guided rational design supplemented with AI-based large protein language model predictions was used to improve rates of DNA target cleavage of a family member, Asp2Cas12l. Compared to the wild-type, engineered variants exhibited an approximately 10-fold increase in double-strand break (DSB) editing efficiency in human cells with less target-to-target variation. Moreover, frequencies of editing were comparable to those of SpCas9 at overlapping target sites, and their DSBs efficiently corrected by homology-directed repair (39–56% of editing outcomes). Altogether, this study extends our understanding of CRISPR-Cas12 protein engineering and offers a potent new alternative for DSB-mediated genome editing in human cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsDNA Breaks, Double-StrandedGene EditingCRISPR-Associated ProteinsHumansEndonucleasesBacterial ProteinsClustered Regularly Interspaced Short Palindromic Repeats

Substanzen

CRISPR-Associated ProteinsEndonucleasesBacterial Proteins

Autor:innen und Institutionen

  • Caszyme, Vilnius, Lithuania.
  • Institute of Biotechnology, Vilnius University, Vilnius, Lithuania.
  • Genome Center of Excellence, Corteva Agriscience™, Johnston, Iowa, USA.

ORCID-Profile: Giedrius Gasiunas

Zitieren

APA

Urbaitis, T., Trinkuniene, L., Lenkaite, I., Petrauskyte, M., Krasauskas, R., Stitilyte, M., Sabaliauskas, M., Sasnauskas, G., Tamulaitiene, G., Young, J. K., Siksnys, V., & Gasiunas, G. (2026). A Potent CRISPR-Cas12l Double-Strand Break Gene Editor. The CRISPR Journal, 9(3), 126-140. https://doi.org/10.1177/25731599261448428

Vancouver

Urbaitis T, Trinkuniene L, Lenkaite I, Petrauskyte M, Krasauskas R, Stitilyte M, et al. A Potent CRISPR-Cas12l Double-Strand Break Gene Editor. The CRISPR Journal. 2026;9(3):126-140. doi:10.1177/25731599261448428

BibTeX
@article{Urbaitis2026,
  author = {Urbaitis, Tomas and Trinkuniene, Laima and Lenkaite, Ieva and Petrauskyte, Monika and Krasauskas, Renatas and Stitilyte, Migle and Sabaliauskas, Modestas and Sasnauskas, Giedrius and Tamulaitiene, Giedre and Young, Joshua K and Siksnys, Virginijus and Gasiunas, Giedrius},
  title = {A Potent CRISPR-Cas12l Double-Strand Break Gene Editor},
  journal = {The CRISPR Journal},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {126--140},
  doi = {10.1177/25731599261448428}
}
Kostenlos starten →